Outcomes in patients with nontriple antiphospholipid syndrome (APS) anticoagulated with rivaroxaban

被引：1

作者：

Htut, Thura Win ^{[1
]}

Milne, Denis ^{[1
]}

Khan, Mohammed M. ^{[1
]}

Watson, Henry G. ^{[1
]}

机构：

[1] Aberdeen Royal Infirm, Dept Haematol, Foresterhill Hlth Campus, Aberdeen, Scotland

来源：

INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY | 2021年 / 43卷 / 05期

关键词：

anticoagulation; antiphospholipid syndrome; rivaroxaban; venous thromboembolism; warfarin; THROMBOSIS; WARFARIN;

D O I：

10.1111/ijlh.13464

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E252 / E253

页数：2

共 50 条

[21] Rivaroxaban to treat thrombotic antiphospholipid syndrome
Urbanus, Rolf T.
Lancet Haematology, 2016, 3 (09): : E403 - E404
[22] Failure of dabigatran and rivaroxaban to prevent thromboembolism in antiphospholipid syndrome: a case series of three patients
Schaefer, Jordan K.
McBane, Robert D.
Black, David F.
Williams, Lindsy N.
Moder, Kevin G.
Wysokinski, Waldemar E.
THROMBOSIS AND HAEMOSTASIS, 2014, 112 (05) : 947 - 950
[23] Outcomes of anticoagulated trauma patients
Ferrera, PC
Bartfield, JM
AMERICAN JOURNAL OF EMERGENCY MEDICINE, 1999, 17 (02) : 154 - 156
[24] Adrenal Hemorrhage in a Patient Anticoagulated with Apixaban with Antiphospholipid Syndrome
Sanford, Zachary
Nanjundappa, Aravinda
Annie, Frank H.
Embrey, Sarah
CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (07)
[25] Thrombosis recurrence and major bleeding in non-anticoagulated thrombotic antiphospholipid syndrome patients: Prospective study from antiphospholipid syndrome alliance for clinical trials and international networking (APS ACTION) clinical database and repository ("Registry")
Yelnik, Cecile M.
Erton, Zeynep Belce
Drumez, Elodie
Cheildze, Dachi
de Andrade, Danieli
Clarke, Ann
Tektonidou, Maria G.
Sciascia, Savino
Pardos-Gea, Jose
Pengo, Vittorio
Ruiz-Irastorza, Guillermo
Belmont, H. Michael
Pedrera, Chary Lopez
Fortin, Paul R.
Wahl, Denis
Gerosa, Maria
Kello, Nina
Signorelli, Flavio
Atsumi, Tatsuya
Ji, Lanlan
Efthymiou, Maria
Branch, D. Ware
Nalli, Cecilia
Rodriguez-Almaraz, Esther
Petri, Michelle
Cervera, Ricard
Shi, Hui
Zuo, Yu
Artim-Esen, Bahar
Pons-Estel, Guillermo
Willis, Rohan
Barber, Megan R. W.
Skeith, Leslie
Bertolaccini, Maria Laura
Cohen, Hannah
Roubey, Robert
Erkan, Doruk
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2024, 65
[26] Outcomes associated with observation status versus inpatient management of pulmonary embolism patients anticoagulated with rivaroxaban
Weeda, Erin R.
Wells, Philip S.
Peacock, W. Frank
Fermann, Gregory J.
Baugh, Christopher W.
Ashton, Veronica
Crivera, Concetta
Wildgoose, Peter
Schein, Jeff R.
Coleman, Craig I.
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 222 : 846 - 849
[27] Damage Index for Antiphospholipid Syndrome (DIAPS): An Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) "Damage" working group report on strengths and limitations
Balbi, Gustavo G. M.
Gaspar, Pedro
Cohen, Hannah
Isenberg, David A.
Erkan, Doruk
Andrade, Danieli
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2025, 70
[28] Anticoagulant Therapy in Patients with Antiphospholipid Syndrome
Capecchi, Marco
Abbattista, Maria
Ciavarella, Alessandro
Uhr, Mario
Novembrino, Cristina
Martinelli, Ida
JOURNAL OF CLINICAL MEDICINE, 2022, 11 (23)
[29] The family history of patients with primary or secondary antiphospholipid syndrome (APS)
Weber, M
Hayem, G
DeBandt, M
Palazzo, E
Roux, S
Kahn, MF
Meyer, O
LUPUS, 2000, 9 (04) : 258 - 263
[30] Trial of Rivaroxaban in AntiPhospholipid Syndrome (TRAPS): Two-year outcomes after the study closure
Pengo, Vittorio
Hoxha, Ariela
Andreoli, Laura
Tincani, Angela
Silvestri, Elena
Prisco, Domenico
Fierro, Tiziana
Gresele, Paolo
Cafolla, Arturo
De Micheli, Valeria
Ghirarduzzi, Angelo
Tosetto, Alberto
Falanga, Anna
Martinelli, Ida
Testa, Sophie
Barcellona, Doris
Gerosa, Maria
Denas, Gentian
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2021, 19 (02) : 531 - 535

← 1 2 3 4 5 →